Clinical Initiative Offerings
To assist our older, most vulnerable population avoid potential ADEs, the following clinical initiatives are available:
Personalized Medication Management with Pharmacogenomic Testing
One in four patients are prescribed at least one medication that commonly causes ADEs due to genetic variability in drug metabolism. In a recent study, 82.5% of patients were prescribed at least one medication that they did not have the genes to metabolize (drug-gene pair interaction). In clinical practice, pharmacogenomics testing aims to identify the risk followed by optimizing and personalizing medication regimens. Pharmacogenomic testing may be of benefit if participants experience ineffectiveness and/or toxicities despite clinical adjustments, particularly for the following medication classes: opioids, anticoagulants, psychotropics, and proton pump inhibitors.
A comprehensive fall management program, with consideration of medication-related risks, is essential as falls, with or without injury, are detrimental in our older adult population. Some risk factors for falls, such as contributing medications, can be modified. Targeted medication reviews are performed with a focus on pertinent therapy changes and medications associated with high fall risk. The goal is prevention of recurrent medication-related participant falls, reduction in hospitalizations, ED utilization and nursing home placement, as well as maintenance of quality of life and independence.
During transitions of care, medication therapy changes often result in unintended discrepancies and potential ADEs. Performing a medication reconciliation and medication review as close to time of discharge as possible, ensures safe and optimal medication regimens. The goal is reduction of 30-day, all-cause re-admissions as well as overall hospitalizations, ED utilization and downstream costs.
Medication Safety Reviews and “Polypharmacy” Calls
To be all encompassing, the medication component is incorporated within the plan of care for participants, upon enrollment, and aligned with annual or semi-annual assessments for those considered to be at highest risk. In addition to ongoing, daily, prospective reviews, comprehensive medication safety reviews are performed with a focus on medication risk mitigation to ensure safe and optimal medication regimens. The goal is reduction of preventable ADEs, hospitalizations, and ED utilization.
Adherence Initiative for Medication Management
Non-adherence may result in poor clinical and economical outcomes, including medication-related hospitalizations and wasteful spending. Participants who may struggle with adherence are identified utilizing assessment tools and in-home observation. By evaluating medication administration behavior and applying interventions, optimal medication management may be achieved.
If interested in learning more about our clinical initiatives collaboration opportunities, please contact PACEClinicalOfferings@carekinesis.com.